current

Its vaccines arm, COVAX, delivered over three quarters of a billion doses globally, despite substantial challenges, such as vaccine hoarding and insufficient transparency from producers. Throughout this uncertain year, we partnered intently with countries on preparing for rollouts. Driving efforts to end the COVID-19 pandemic, WHO has led the cost for fairness. We have set…